English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

Azamacrocyclic Ca2+ Sensitive Contrast Agents for MR Imaging

MPS-Authors
/persons/resource/persons84074

Mamedov,  I
Department Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons83784

Angelovski,  G
Department Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84063

Logothetis,  NK
Department Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)

SMI-2007-Mamedov.pdf
(Any fulltext), 18KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Mamedov, I., Angelovski, G., Henig, J., Mayer, H., & Logothetis, N. (2007). Azamacrocyclic Ca2+ Sensitive Contrast Agents for MR Imaging. Poster presented at AMI/SMI Joint Molecular Imaging Conference 2007, Providence, RI, USA.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0013-CC13-A
Abstract
As calcium plays an important role in regulating a great variety of neuronal processes, many efforts are already made to generate gadolinium complexes that can act as a calcium-sensors in MRI.1 We developed a series of the DO3A-based macrocyclic and bismacrocyclic gadolinium chelates, bearing phosphonate groups as an additional coordination sites. These complexes are hypothesized to change the MRI contrast dynamically with Ca2+ concentration. Different lengths of the phosphonate side chains are exploited for fine-tuning the sensitivity of the agent to calcium ion concentration.